Six New Medical Technologies Worth Watching

via Wall Street Journal

From growing blood vessels in labs to applying advanced nanotechnology to cancer testing, here are some emerging technologies that could have a big impact on medicine in coming years.

Engineered Blood Vessels

Humacyte Inc., a Morrisville, N.C., startup, is notching big advances in growing human tissue in labs that can be implanted safely in the body. Its lead product is a blood vessel designed for patients undergoing kidney dialysis.

The company uses donor cells to grow the human tissue needed to make the blood vessels. It cleanses the donor cells from the vessels before implanting them, so patients’ immune systems don’t reject them.

Two midstage studies published in the Lancet in May showed patients’ natural cells merged with the engineered blood vessels, which could make them less prone to infection and more durable than the metal tubes often used to facilitate blood flow in dialysis patients. Humacyte hopes to bring the first bioengineered blood vessel to the U.S. around 2019.

Read the full article here

Advertisements

About thebenefitblog

Eric is a Producer at Lockton Insurance Brokers, Inc., the world’s largest privately held commercial broker. Eric has over 23 years of experience in the insurance industry and has spent the last 11 years with Lockton. Eric specializes in Health & Welfare Benefits, Retirement Planning, and Executive Benefits. Eric's clients utilize his expertise in the areas of Plan Due Diligence, Transaction Structure, Fiduciary Oversight, Investment Design, Compliance and Vendor negotiation to improve the operational & financial outcome for each client. The Benefit Blog is a place to share that expertise and industry news.
This entry was posted in Uncategorized. Bookmark the permalink.